Enzootic bovine leucosis (EBL) is a neoplastic disease caused by Bovine leukaemia virus (BLV) (Bartlett et al., 2014). BLV infection occurs in three possible stages: the aleukaemic stage, persistent lymphocytosis (PL) stage and EBL stage (Dequiedt et al., 1999). It is estimated that approximately 30% of BLV-infected cattle are in the PL stage, and fewer than 5% of those develop fatal B-cell lymphosarcoma (Rodríguez et al., 2011). This disease has an economic impact because it causes direct economic losses by reducing milk production and fertility, and through cattle condemnation and death (Kale et al., 2007). A great amount of efforts was directed to BLV elimination during the period 1993-2010 (EFSA Panel on Animal Health and Welfare (AHAW) et al., 2017) in the European Union (EU). As a result, most of its member states have officially declared EBL-free. In Japan, on the other hand, the nationwide survey of BLV infection from 2009 to 2011 showed that the prevalence of BLV infection in animal level was 40.9%